$24.04
+1.01
(+4.39%)▲
2.37%
Downside
Day's Volatility :2.69%
Upside
0.33%
62.9%
Downside
52 Weeks Volatility :62.9%
Upside
0.0%
Period | Biolife Solutions, Inc. | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 31.37% | 6.5% | 0.0% |
6 Months | 31.75% | 7.1% | 0.0% |
1 Year | 18.47% | 9.8% | 0.0% |
3 Years | -49.12% | 14.2% | -20.2% |
Market Capitalization | 1.0B |
Book Value | $7.3 |
Earnings Per Share (EPS) | -1.42 |
PEG Ratio | 65.38 |
Wall Street Target Price | 25.44 |
Profit Margin | -45.84% |
Operating Margin TTM | -31.18% |
Return On Assets TTM | -8.04% |
Return On Equity TTM | -18.2% |
Revenue TTM | 137.3M |
Revenue Per Share TTM | 3.1 |
Quarterly Revenue Growth YOY | -15.9% |
Gross Profit TTM | 54.1M |
EBITDA | -43.1M |
Diluted Eps TTM | -1.42 |
Quarterly Earnings Growth YOY | 6.4 |
EPS Estimate Current Year | -0.57 |
EPS Estimate Next Year | -0.36 |
EPS Estimate Current Quarter | -0.28 |
EPS Estimate Next Quarter | -0.21 |
What analysts predicted
Upside of 5.82%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 19.7M | ↑ 79.11% |
Net Income | 3.3M | ↓ 229.86% |
Net Profit Margin | 16.54% | ↑ 39.36% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 27.4M | ↑ 38.64% |
Net Income | 11.1M | ↑ 238.7% |
Net Profit Margin | 40.42% | ↑ 23.88% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 48.1M | ↑ 75.69% |
Net Income | 2.7M | ↓ 75.89% |
Net Profit Margin | 5.55% | ↓ 34.87% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 119.2M | ↑ 147.79% |
Net Income | -8.4M | ↓ 414.32% |
Net Profit Margin | -7.04% | ↓ 12.59% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 161.8M | ↑ 35.75% |
Net Income | -139.8M | ↑ 1567.72% |
Net Profit Margin | -86.43% | ↓ 79.39% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 143.3M | ↓ 11.43% |
Net Income | -66.4M | ↓ 52.49% |
Net Profit Margin | -46.36% | ↑ 40.07% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 44.3M | ↑ 8.62% |
Net Income | -49.2M | ↑ 394.02% |
Net Profit Margin | -111.14% | ↓ 86.7% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 37.7M | ↓ 14.81% |
Net Income | -13.7M | ↓ 72.12% |
Net Profit Margin | -36.37% | ↑ 74.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 39.5M | ↑ 4.79% |
Net Income | -10.2M | ↓ 25.63% |
Net Profit Margin | -25.82% | ↑ 10.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 33.3M | ↓ 15.64% |
Net Income | -29.1M | ↑ 185.64% |
Net Profit Margin | -87.41% | ↓ 61.59% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 32.7M | ↓ 1.79% |
Net Income | -13.4M | ↓ 54.06% |
Net Profit Margin | -40.89% | ↑ 46.52% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 31.7M | ↓ 3.07% |
Net Income | -10.2M | ↓ 23.63% |
Net Profit Margin | -32.22% | ↑ 8.67% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 45.5M | ↑ 274.43% |
Total Liabilities | 2.3M | ↑ 13.07% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 93.0M | ↑ 104.57% |
Total Liabilities | 10.0M | ↑ 330.57% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 234.8M | ↑ 152.47% |
Total Liabilities | 29.6M | ↑ 196.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 552.6M | ↑ 135.32% |
Total Liabilities | 71.9M | ↑ 142.89% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 450.2M | ↓ 18.53% |
Total Liabilities | 86.0M | ↑ 19.75% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 412.7M | ↓ 8.33% |
Total Liabilities | 75.1M | ↓ 12.77% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 450.2M | ↓ 7.68% |
Total Liabilities | 86.0M | ↑ 8.32% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 446.5M | ↓ 0.83% |
Total Liabilities | 88.4M | ↑ 2.7% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 433.2M | ↓ 2.98% |
Total Liabilities | 81.0M | ↓ 8.28% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 411.2M | ↓ 5.08% |
Total Liabilities | 79.1M | ↓ 2.36% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 412.7M | ↑ 0.38% |
Total Liabilities | 75.1M | ↓ 5.16% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 401.6M | ↓ 2.69% |
Total Liabilities | 68.2M | ↓ 9.13% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.3M | ↑ 288.1% |
Investing Cash Flow | -6.5M | ↑ 4421.2% |
Financing Cash Flow | 28.1M | ↑ 486.86% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2M | ↓ 48.34% |
Investing Cash Flow | -27.0M | ↑ 315.66% |
Financing Cash Flow | 1.6M | ↓ 94.33% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 6.5M | ↑ 437.1% |
Investing Cash Flow | -23.7M | ↓ 12.17% |
Financing Cash Flow | 101.2M | ↑ 6242.36% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.8M | ↓ 174.23% |
Investing Cash Flow | -12.6M | ↓ 46.73% |
Financing Cash Flow | -2.8M | ↓ 102.74% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -8.5M | ↑ 75.54% |
Investing Cash Flow | -58.1M | ↑ 359.71% |
Financing Cash Flow | 16.3M | ↓ 687.37% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.9M | ↑ 425.13% |
Investing Cash Flow | -14.9M | ↓ 6.23% |
Financing Cash Flow | -624.0K | ↓ 103.58% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.7M | ↓ 134.52% |
Investing Cash Flow | 2.9M | ↓ 119.65% |
Financing Cash Flow | -562.0K | ↓ 9.94% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -7.7M | ↑ 184.59% |
Investing Cash Flow | 9.3M | ↑ 217.57% |
Financing Cash Flow | 704.0K | ↓ 225.27% |
Sell
Neutral
Buy
Biolife Solutions, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Biolife Solutions, Inc. | 7.17% | 31.75% | 18.47% | -49.12% | 19.57% |
![]() Intuitive Surgical, Inc. | -1.32% | 16.54% | 32.6% | 35.62% | 148.32% |
![]() Resmed Inc. | 11.69% | 9.57% | -6.0% | -19.79% | 64.22% |
![]() Becton, Dickinson And Company | 0.5% | -1.64% | -17.69% | -6.68% | -8.49% |
![]() West Pharmaceutical Services Inc | -14.37% | -23.3% | -26.95% | -26.58% | 102.44% |
![]() Alcon Ag | 2.41% | 20.84% | 8.21% | 30.7% | 54.72% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Biolife Solutions, Inc. | NA | NA | 65.38 | -0.57 | -0.18 | -0.08 | NA | 7.3 |
![]() Intuitive Surgical, Inc. | 78.14 | 78.14 | 7.13 | 6.63 | 0.16 | 0.08 | NA | 41.4 |
![]() Resmed Inc. | 32.24 | 32.24 | 1.75 | 7.73 | 0.22 | 0.12 | 0.01 | 31.52 |
![]() Becton, Dickinson And Company | 50.71 | 50.71 | 1.34 | 13.04 | 0.05 | 0.03 | 0.02 | 88.74 |
![]() West Pharmaceutical Services Inc | 42.71 | 42.71 | 6.72 | 7.74 | 0.21 | 0.11 | 0.0 | 36.72 |
![]() Alcon Ag | 44.05 | 44.05 | 4.59 | 3.07 | 0.05 | 0.02 | 0.0 | 42.13 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Biolife Solutions, Inc. | Buy | $1.0B | 19.57% | NA | -45.84% |
![]() Intuitive Surgical, Inc. | Buy | $161.3B | 148.32% | 78.14 | 27.65% |
![]() Resmed Inc. | Buy | $30.8B | 64.22% | 32.24 | 20.91% |
![]() Becton, Dickinson And Company | Buy | $68.6B | -8.49% | 50.71 | 6.76% |
![]() West Pharmaceutical Services Inc | Buy | $23.7B | 102.44% | 42.71 | 19.42% |
![]() Alcon Ag | Buy | $45.8B | 54.72% | 44.05 | 10.96% |
Insights on Biolife Solutions, Inc.
Revenue is down for the last 4 quarters, 39.50M → 31.72M (in $), with an average decrease of 6.8% per quarter
Netprofit is up for the last 3 quarters, -29.13M → -10.22M (in $), with an average increase of 74.3% per quarter
In the last 1 year, Intuitive Surgical, Inc. has given 32.6% return, outperforming this stock by 14.1%
In the last 3 years, Intuitive Surgical, Inc. has given 35.6% return, outperforming this stock by 84.7%
Casdin Capital, LLC
BlackRock Inc
Vanguard Group Inc
Millennium Management LLC
William Blair Investment Management, LLC
Fred Alger Management, LLC
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Organization | Biolife Solutions, Inc. |
Employees | 409 |
CEO | Mr. Roderick de Greef |
Industry | Health Technology |
A Spac I Acquisition Corp
$24.04
+4.39%
Keyarch Acquisition Corp
$24.04
+4.39%
Connexa Sports Technologies Inc
$24.04
+4.39%
Us Value Etf
$24.04
+4.39%
First Wave Biopharma Inc
$24.04
+4.39%
Global X Msci Next Emerging
$24.04
+4.39%
Fat Projects Acquisition Corp
$24.04
+4.39%
Capital Link Global Fintech
$24.04
+4.39%
Applied Uv Inc
$24.04
+4.39%